세계의 의약품 시험 및 분석 서비스 시장 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2032년)

The global demand for Pharmaceutical Testing and Analytical Services Market is presumed to reach the market size of nearly USD 14.91 Billion by 2032 from USD 7.98 Billion in 2023 with a CAGR of 7.19% under the study period 2024 - 2032.

Pharmaceutical testing and analytical services encompass a range of laboratory techniques and methods used to assess the safety, quality, and effectiveness of pharmaceutical ingredients & products. These services involve testing pharmaceutical raw materials, intermediates, and finished products to ensure compliance with regulatory standards, pharmacopeial requirements, and quality specifications. Pharmaceutical testing may include chemical analysis, microbiological testing, stability testing, dissolution testing, and bioavailability studies. Analytical services provide critical information on pharmaceutical formulations' identity, purity, potency, and stability, supporting drug development, manufacturing, and regulatory approval processes.

MARKET DYNAMICS

The increasing emphasis by regulatory authorities on drug safety, efficacy, and quality drives the demand for comprehensive testing and analytical services. Pharmaceutical testing and analytical services are crucial in ensuring compliance with regulatory standards, identifying impurities, and validating pharmaceutical products' potency, stability, and purity. Moreover, the growing complexity of drug formulations, including biologics, biosimilars, and specialty drugs, drives the need for advanced analytical techniques and specialized testing services to adhere to regulatory requirements and ensure product quality. Additionally, the expanding pharmaceutical and biotechnology industry, driven by factors such as surging R&D investments, spurring prevalence of chronic diseases, and growing demand for personalized medicine, is fueling the demand for outsourced testing and analytical services from contract research organizations (CROs) and contract manufacturing organizations (CMOs). Furthermore, the spurring adoption of advanced technologies such as mass spectrometry, chromatography, spectroscopy, and molecular diagnostics in pharmaceutical testing and analytical services is enhancing analytical methods' accuracy, sensitivity, and throughput, thereby driving market growth.

Moreover, the rising trend of outsourcing non-core activities, cost containment strategies, and operational efficiencies in the pharmaceutical industry is driving the demand for outsourcing testing and analytical services to specialized providers. Additionally, the expanding regulatory requirements for product characterization, process validation, and quality control drive the demand for specialized testing services that offer expertise in compliance, method development, and validation. Furthermore, the growing focus on biosafety, biosecurity, and contamination control in pharmaceutical manufacturing facilities is driving the demand for environmental monitoring, microbial testing, and sterility testing services, contributing to market growth. However, increasing competition and regulatory requirements may challenge the development of the pharmaceutical testing and analytical services market in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of pharmaceutical testing and analytical services. The growth and trends of pharmaceutical testing and analytical services industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the pharmaceutical testing and analytical services market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Service Type

• Bioanalytical Testing (Cell-Based Assays, Virology Testing, And Others)
• Method Development & Validation (Extractables & Leachables Method Development And Validation, Stability-Indicating Method Validation, Process Impurity Method Development & Validation, And Others)
• Raw Material Testing (Heavy Metal Testing, Complete Compendial Testing, And Others)
• Stability Testing (Drug Substance Stability Testing, Formulation Evaluation Stability Testing, And Others)
• Microbial Testing (Microbial Limit Testing, Sterility Testing, Endotoxin Testing, And Others)
• Others

By End-User

• Medical Device Companies
• Pharmaceutical & Biopharmaceutical Companies
• Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Pharmaceutical Testing and Analytical Services market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Pharmaceutical Testing and Analytical Services market include Eurofins Scientific, Laboratory Corporation of America Holdings, Charles River Laboratories International, Inc., SGS S.A., Intertek Group plc, RD laboratories, Inc., Wuxi AppTec Co., Ltd., Dynalabs LLC (Infinity Laboratories), ARL Bio Pharma. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . PHARMACEUTICAL TESTING AND ANALYTICAL SERVICES - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Service Type
  • 3.7.2 Market Attractiveness Analysis By End-user
  • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL PHARMACEUTICAL TESTING AND ANALYTICAL SERVICES MARKET ANALYSIS BY SERVICE TYPE

• 5.1 Overview by Service Type
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Service Type
• 5.4 Bioanalytical Testing (Cell-based Assays, Virology Testing, and Others) Historic and Forecast Sales by Regions
• 5.5 Method Development & Validation (Extractables & Leachables Method Development and Validation, Stability-indicating Method Validation, Process Impurity Method Development & Validation, and Others) Historic and Forecast Sales by Regions
• 5.6 Raw Material Testing (Heavy Metal Testing, Complete Compendial Testing, and Others) Historic and Forecast Sales by Regions
• 5.7 Stability Testing (Drug Substance Stability Testing, Formulation Evaluation Stability Testing, and Others) Historic and Forecast Sales by Regions
• 5.8 Microbial Testing (Microbial Limit Testing, Sterility Testing, Endotoxin Testing, and Others) Historic and Forecast Sales by Regions
• 5.9 Others Historic and Forecast Sales by Regions

6 . GLOBAL PHARMACEUTICAL TESTING AND ANALYTICAL SERVICES MARKET ANALYSIS BY END-USER

• 6.1 Overview by End-user
• 6.2 Historical and Forecast Data
• 6.3 Analysis by End-user
• 6.4 Medical Device Companies Historic and Forecast Sales by Regions
• 6.5 Pharmaceutical & Biopharmaceutical Companies Historic and Forecast Sales by Regions
• 6.6 Others Historic and Forecast Sales by Regions

7 . GLOBAL PHARMACEUTICAL TESTING AND ANALYTICAL SERVICES MARKET ANALYSIS BY GEOGRAPHY

• 7.1. Regional Outlook
• 7.2. Introduction
• 7.3. North America Sales Analysis
  • 7.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.3.2. North America By Segment Sales Analysis
  • 7.3.3. North America By Country Sales Analysis
  • 7.3.4. United State Sales Analysis
  • 7.3.5. Canada Sales Analysis
  • 7.3.6. Mexico Sales Analysis
• 7.4. Europe Sales Analysis
  • 7.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.4.2. Europe by Segment Sales Analysis
  • 7.4.3. Europe by Country Sales Analysis
  • 7.4.4. United Kingdom Sales Analysis
  • 7.4.5. France Sales Analysis
  • 7.4.6. Germany Sales Analysis
  • 7.4.7. Italy Sales Analysis
  • 7.4.8. Russia Sales Analysis
  • 7.4.9. Rest Of Europe Sales Analysis
• 7.5. Asia Pacific Sales Analysis
  • 7.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.5.2. Asia Pacific by Segment Sales Analysis
  • 7.5.3. Asia Pacific by Country Sales Analysis
  • 7.5.4. China Sales Analysis
  • 7.5.5. India Sales Analysis
  • 7.5.6. Japan Sales Analysis
  • 7.5.7. South Korea Sales Analysis
  • 7.5.8. Australia Sales Analysis
  • 7.5.9. South East Asia Sales Analysis
  • 7.5.10. Rest Of Asia Pacific Sales Analysis
• 7.6. Latin America Sales Analysis
  • 7.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.6.2. Latin America by Segment Sales Analysis
  • 7.6.3. Latin America by Country Sales Analysis
  • 7.6.4. Brazil Sales Analysis
  • 7.6.5. Argentina Sales Analysis
  • 7.6.6. Peru Sales Analysis
  • 7.6.7. Chile Sales Analysis
  • 7.6.8. Rest of Latin America Sales Analysis
• 7.7. Middle East & Africa Sales Analysis
  • 7.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.7.2. Middle East & Africa by Segment Sales Analysis
  • 7.7.3. Middle East & Africa by Country Sales Analysis
  • 7.7.4. Saudi Arabia Sales Analysis
  • 7.7.5. UAE Sales Analysis
  • 7.7.6. Israel Sales Analysis
  • 7.7.7. South Africa Sales Analysis
  • 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE PHARMACEUTICAL TESTING AND ANALYTICAL SERVICES COMPANIES

• 8.1. Pharmaceutical Testing And Analytical Services Market Competition
• 8.2. Partnership/Collaboration/Agreement
• 8.3. Merger And Acquisitions
• 8.4. New Product Launch
• 8.5. Other Developments

9 . COMPANY PROFILES OF PHARMACEUTICAL TESTING AND ANALYTICAL SERVICES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Market Concentration Rate
• 9.3. Eurofins Scientific
  • 9.3.1. Company Overview
  • 9.3.2. Company Revenue
  • 9.3.3. Products
  • 9.3.4. Recent Developments
• 9.4. Laboratory Corporation of America Holdings
  • 9.4.1. Company Overview
  • 9.4.2. Company Revenue
  • 9.4.3. Products
  • 9.4.4. Recent Developments
• 9.5. Charles River Laboratories International Inc.
  • 9.5.1. Company Overview
  • 9.5.2. Company Revenue
  • 9.5.3. Products
  • 9.5.4. Recent Developments
• 9.6. SGS S.A.
  • 9.6.1. Company Overview
  • 9.6.2. Company Revenue
  • 9.6.3. Products
  • 9.6.4. Recent Developments
• 9.7. Intertek Group plc
  • 9.7.1. Company Overview
  • 9.7.2. Company Revenue
  • 9.7.3. Products
  • 9.7.4. Recent Developments
• 9.8. RD laboratories Inc.
  • 9.8.1. Company Overview
  • 9.8.2. Company Revenue
  • 9.8.3. Products
  • 9.8.4. Recent Developments
• 9.9. Wuxi AppTec Co. Ltd.
  • 9.9.1. Company Overview
  • 9.9.2. Company Revenue
  • 9.9.3. Products
  • 9.9.4. Recent Developments
• 9.10. Dynalabs LLC (Infinity Laboratories)
  • 9.10.1. Company Overview
  • 9.10.2. Company Revenue
  • 9.10.3. Products
  • 9.10.4. Recent Developments
• 9.11. ARL Bio Pharma
  • 9.11.1. Company Overview
  • 9.11.2. Company Revenue
  • 9.11.3. Products
  • 9.11.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies